| Filed On | Filing |
|---|---|
| 18 Mar 2016 |
8-K/A: Financial Statements and Exhibits
LA JOLLA, Calif., March 17, 2016 – Kura Oncology, Inc., (NASDAQ: KURA) a clinical stage biopharmaceutical company, today announced highlights and financial results for the fourth quarter and full year ended December 31, 2015. |
| 02 Jul 2015 |
8-K/A: Financial Statements and Exhibits
***Text Omitted and Filed Separately with the Securities and Exchange Commission. |
Loading...